The Cedars-Sinai Thyroid Cancer Program is part of the Southern California Thyroid Cancer Consortium Center. The consortium is a group of major academic, public and private medical centers and universities with physicians and researchers investigating many aspects of thyroid cancer. The goal of the consortium is to develop new diagnostic tests and treatments for thyroid cancer, and to ensure that the latest advances in the field of thyroid cancer are disseminated to other physicians as rapidly as possible. In partnership with the National Cancer Institute, private industry and national and international thyroid cancer centers, Cedars-Sinai and its consortium partners seek to apply an innovative and multidisciplinary approach to treating thyroid cancer that includes endocrinologists, oncologists, surgeons, pathologists, nuclear medicine specialists and radiologists.
The Southern California Thyroid Cancer Center Consortium members include:
- Harbor — University of California, Los Angeles
- University of California, Los Angeles — Westwood
- West LA Veterans Administration
- University of Southern California
For more information, please visit the consortium's website here.